Dermpath München
Research facility
Location:
München,
Germany (DE)
ISNI: -
Nuclear NR4A2 (Nurr1) Immunostaining is a Novel Marker for Acinic Cell Carcinoma of the Salivary Glands Lacking the Classic NR4A3 (NOR-1) Upregulation (2020)
Haller F, Moskalev E, Kuck S, Bieg M, Winkelmann C, Müller S, Ihrler S, et al.
Journal article
Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands (2019)
Haller F, Skálová A, Ihrler S, Märkl B, Bieg M, Moskalev E, Erber R, et al.
Journal article